Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
25 September 2020Website:
http://www.preludetx.comNext earnings report:
02 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 18:10:22 GMTDividend
Analysts recommendations
Institutional Ownership
PRLD Latest News
WILMINGTON, Del., June 03, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in two upcoming healthcare conferences in June.
Prelude Therapeutics Incorporated (PRLD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Eight Abstracts Demonstrate Progress of Prelude's Differentiated Pipeline Eight Abstracts Demonstrate Progress of Prelude's Differentiated Pipeline
What type of business is Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid tumors, including glioblastoma multiforme. The company is also developing PRT1419, a potent and selective inhibitor of the anti-apoptotic protein; PRT2527, a potent inhibitor of CDK9 that exhibits high kinome selectivity; PRT-SCA2, which is in preclinical stage for multiple genomically selected cancers; PRT3645, a brain penetrant molecule that potently and selectively targets CDK4/6; and PRT-K4 that is in preclinical stage for solid tumors. The company was incorporated in 2016 and is headquartered in Wilmington, Delaware.
What sector is Prelude Therapeutics Incorporated in?
Prelude Therapeutics Incorporated is in the Healthcare sector
What industry is Prelude Therapeutics Incorporated in?
Prelude Therapeutics Incorporated is in the Biotechnology industry
What country is Prelude Therapeutics Incorporated from?
Prelude Therapeutics Incorporated is headquartered in United States
When did Prelude Therapeutics Incorporated go public?
Prelude Therapeutics Incorporated initial public offering (IPO) was on 25 September 2020
What is Prelude Therapeutics Incorporated website?
https://www.preludetx.com
Is Prelude Therapeutics Incorporated in the S&P 500?
No, Prelude Therapeutics Incorporated is not included in the S&P 500 index
Is Prelude Therapeutics Incorporated in the NASDAQ 100?
No, Prelude Therapeutics Incorporated is not included in the NASDAQ 100 index
Is Prelude Therapeutics Incorporated in the Dow Jones?
No, Prelude Therapeutics Incorporated is not included in the Dow Jones index
When does Prelude Therapeutics Incorporated report earnings?
The next expected earnings date for Prelude Therapeutics Incorporated is 02 August 2024